12:00 PM Registration and Buffet Meal
12:15 PM Program Overview
12:25 PM Multidrug-Resistant HIV: The Scope of the Problem
- Prevalence of MDR HIV in the US
- Identification of patients with MDR HIV
- Principles for constructing ART regimens for patients with MDR HIV
12:45 PM Case Studies
- Identifying and selecting optimal ART regimens for multidrug-resistant HIV patients
- Emerging investigational agents for treating MDR HIV
- Which patients should be referred to specialists?
1:15 PM Question and Answer Session
1:30 PM Adjournment
Date / Time
Eric Daar, MD
Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California
Daniel R. Kuritzkes, MD
Chief, Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
You are invited to attend a live, interactive CME/CE-certified symposium in which expert faculty will discuss key strategies to identify and manage highly treatment–experienced patients with multidrug-resistant HIV.
The goal of this activity is to improve participants’ competence in identifying and treating patients with multidrug-resistant HIV.
This activity is intended for physicians, registered nurses, pharmacists, and other healthcare professionals involved in the care of patients infected with HIV.
Upon completion of this activity, participants should be able to:
- Implement practical strategies to identify multidrug-resistant HIV among highly treatment–experienced patients
- Apply best practices for the selection of optimal individualized regimens for treatment-experienced patients
- Appraise emerging options for the management of patients with multidrug-resistant HIV who cannot achieve virologic suppression using currently approved agents
Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Clinical Care Options, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
This educational activity for 1.2 contact hour is provided by Postgraduate Institute for Medicine.
Postgraduate Institute for Medicine is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you within 4 weeks.
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Postgraduate Institute for Medicine designates this continuing education activity for 1.25 contact hour (0.125 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - ACPE UAN is 0809-9999-17-504-L02-P)
Type of Activity: Application
For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.